Let's see what strategy makes sense today.
EBS has been in an uptrend for a long time.
This biotech is on the front lines of oncology treatments.
Let's check out the charts and indicators of EL.
Trading volume in the disinfectant maker's shares has been very active since February, which coincides with rising coronavirus fears.
Avoid the long side for now.
I don't see clear signs of aggressive buying.
CEO Rodriguez said he's seeing some indications that the economy has bottomed and is getting a general feeling that the worst is now behind us.
Consumers are heating up the demand for CPB's products.
There are positive technical signals for the restaurant opeator's shares, but further gains could run into a ceiling.